Imprimis Pharmaceuticals Sells Off Facility In PA

San Diego-based pharmaceuticals developer Imprimis Pharmaceuticals said that it sold off its Folcroft, Pennsylvania facility, and related assets in the sinus business, in a deal worth $450,000. According to Imprimis, the deal will help it focus its resources on its core ophthalmology business. Imprimis said the move was an "important step towards reducing non-strategic overhead expenses."